Daily GLP-1 medications (Saxenda and Victoza, both liraglutide) are a different experience from weekly injections. The medication works similarly, but the daily rhythm creates unique challenges and opportunities.

Daily vs. weekly: what's different.

Adherence is everything. A weekly injection gives you one moment per week to remember. A daily injection gives you 365 moments per year. Missing a weekly dose means 1/52 of your annual medication. Missing a daily dose happens more easily and more often.

The side effect profile is milder. Liraglutide causes less nausea than semaglutide in head-to-head trials (STEP 8). The trade-off: liraglutide produces about 6% body weight loss vs. 16% for semaglutide at optimal doses.

The forgetting pattern is real. There's a paradox unique to daily GLP-1: the medication suppresses appetite → you eat less → you feel fine → you forget to inject → appetite returns. Breaking this cycle requires making the injection automatic. Tie it to a daily routine, not to how you feel.

Worth remembering
The "feel-fine-forget" paradox is unique to daily GLP-1. When the medication works, you stop feeling like you need it, and you skip a dose. Tie the injection to an existing habit, not to how you feel.

Building the daily habit.

The users who succeed with daily GLP-1 share common strategies:

Liraglutide titration.

WeeksDoseNotes
10.6 mgStarting dose
21.2 mgFirst increase
31.8 mgSecond increase
42.4 mgThird increase
5+3.0 mgFull maintenance dose

Escalation happens faster than weekly medications: one week per step rather than four. If you struggle with side effects at any level, your doctor may slow the schedule.

Read next Injection guide: quick reference

If you miss a dose.

When liraglutide makes sense.

Liraglutide isn't the strongest GLP-1 on the market, but it fills important niches:

Sources

  1. FDAWegovy FDA Prescribing Information (2025)
  2. META-ANALYSISGI safety of semaglutide and tirzepatide: systematic review (PMC)
  3. REVIEWGLP-1 RA general guide: liraglutide and class overview (NCBI StatPearls)
  4. REVIEWGLP-1 RA adverse effects review (PMC)
  5. COHORTReal-world titration and persistence (Wiley DOM)

This article is for educational purposes only and is not medical advice. Always consult your healthcare provider about your specific situation.